# FDG PET-MRI for the Diagnosis of Spinal Cord Lesions

> **NCT04219969** · NA · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 11 (actual)

## Conditions studied

- Spinal Cord Neoplasm

## Interventions

- **DRUG:** Fludeoxyglucose F-18
- **DEVICE:** Magnetic Resonance Imaging
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT04219969
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-21
- **Primary completion:** 2024-05-07
- **Final completion:** 2024-05-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2024-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04219969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04219969, "FDG PET-MRI for the Diagnosis of Spinal Cord Lesions". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04219969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*